If such technology is made available commercially, it could revolutionize magnetic resonance imaging, noted Stephan Anderson, a Boston Medical Center radiologist and BU School of Medicine professor of radiology.
As part of the collaboration, Yale New Haven Hospital has been using the MRI system for a two-year study involving the American Heart Association. Results of the preliminary research will be announced early next year.
18 fluorodeoxyglucose (FDG) PET/CT imaging can help predict outcomes of patients who have been newly diagnosed with multiple myeloma, according to a study published in the American Journal of Roentgenology.
The aggressiveness with which some low-risk cancers are surveilled has more to do with the preferences of the patient than the state of the disease. Consequently, patients who want more scans and tests tend to raise their costs and risks of overtreatment without improving their outcomes.